Cytek Biosciences, Inc. (CTKB) Misses Q2 EPS by 4c

Cytek Biosciences, Inc. (NASDAQ: CTKB) reported Q2 EPS of ($0.03), $0.04 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $49.69 million versus the consensus estimate of $45.71 million.

For earnings history and earnings-related data on Cytek Biosciences, Inc. (CTKB) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• 51Talk Online Education Group (COE) Reports Q1 EPS of $0.00
• Lennar Corp. (LEN) Misses Q2 EPS by 1c